Position in INCY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$8,686,436
+$3,011,000 QoQ
Shares Held
76,627
+27.1% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#181
of 854 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mediolanum International Funds Ltd holds $75,305,474 across 10 Biotechnology names. INCY ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
29,785 | $27,633,629 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,396 | $13,966,587 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,754 | $9,199,709 | |
| 4 | INCY |
Incyte Corp
This page
|
76,627 | $8,686,436 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
15,940 | $5,924,419 | |
| 6 | ASND |
Ascendis Pharma A/S
|
11,697 | $3,119,823 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,776 | $2,869,112 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
28,940 | $2,358,899 |
All Filings in INCY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,686,436 | 76,627 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,675,436 | 60,300 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,748,170 | 48,073 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,295,891 | 27,071 | Shares | Sole | 2025-11-04 | |
| 2024-12-31 | $1,444,668 | 20,916 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,562,405 | 23,637 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $6,306,237 | 104,029 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,181,272 | 20,735 | Shares | Sole | 2024-05-03 | |
| No filing history on record for this holder in this stock. | ||||||